Fallopian Tube Sperm Perfusion (FSP) Versus Intra-uterine Insemination (IUI) in Natural Cycle
NCT ID: NCT00816387
Last Updated: 2010-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
400 participants
INTERVENTIONAL
2007-10-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IUI
Intrauterine insemination using standard catheter
Intrauterine insemination using standard catheter
Patients are treated with standard intrauterine insemination
FSP
Fallopian tube sperm perfusion using a commercial device for hysterosalpingography and tubal hydropertubation
Fallopian tube sperm perfusion
Patients are treated with fallopian tube sperm perfusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fallopian tube sperm perfusion
Patients are treated with fallopian tube sperm perfusion
Intrauterine insemination using standard catheter
Patients are treated with standard intrauterine insemination
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \<40 years
* unexplained infertility or mild male factor
Exclusion Criteria
24 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Burlo Garofolo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
IRCCS Burlo Garofolo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe Ricci, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Burlo Garofolo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Burlo Garofolo
Trieste, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RU01/07
Identifier Type: -
Identifier Source: org_study_id